SOURCE: Medical Marijuana Inc

March 25, 2010 07:20 ET

Medical Marijuana Inc Licenses Clothing Line and Will Provide Hemp Paper to Its TA for Stock Certificates and Provides Other News

FOOTHILL RANCH, CA--(Marketwire - March 25, 2010) - Medical Marijuana Inc (PINKSHEETS: MJNA) is proud to announce the licensing of its clothing line, the future use of hemp paper for its stock certificates, the receipt of payment for consulting services provided to Health Sciences, Inc., and more.

The company entered into an agreement with a small public company (to be named in future press release) that will market a clothing line licensed by MJNA. MJNA shareholders will receive approximately 1 restricted share as a dividend of that OTC Markets company based on each 2 MJNA shares now held by MJNA shareholders.

Chairman Bruce Perlowin stated, "Since HEMP is an important part of the Marijuana industries, using this superior paper helps to emphasize its importance and we will later announce the date when our stock certificates will be available in hemp paper so that shareholders will have the opportunity to order stock certificates from our transfer agent."

Medical Marijuana Inc was also paid 200,000,000 shares (pursuant to SEC Rule 144) of Health Sciences, Inc. (HESG) for Marijuana industry consulting services provided to HESG. 

MJNA's licensee will reveal its clothing line at the upcoming San Diego Seminar March 27. To get ahead of the learning curve and join the exploding cannabis industries, buy your tickets to the San Diego Symposium at http://www.medicalmarijuanaeducationalexpo.com/

Medical Marijuana Inc's Symposium on Saturday follows in the footsteps of the San Diego City Council 3-2 vote deciding to pursue a Medical Marijuana Ordinance rather than impose a moratorium on Medical Marijuana dispensaries.

MJNA's Chairman Bruce Perlowin will be interviewed on Saturday at the San Diego Convention Center Symposium by the Latin Television Network, Televisa, the largest media company in the Spanish speaking world. The show will be aired nationally in Mexico on April 8, 2010.

Medical Marijuana Educational Seminars

Additionally we will be launching and teaching an entirely New Business Opportunity for Anyone wanting to get into the Medical Marijuana industry that until recently did not exist. An entrepreneurial opportunity that is faster to get up and running and earning income; one that is safer than opening a collective dispensary or grow operation with all the shifting laws and unsure and unstable battling political environments, and one you can open in any state regardless of where that state is in the legalization process.

These kinds of seminars are filled with people wanting to learn how to enter the Medical Marijuana Business. Therefore, we will be presenting our ground breaking new Medical Marijuana Institute Educational Center business opportunity where the licensed Center owner receives 60% of the ticket sales and a percentage of all products & services offered through them by licensor MJNA. You can extrapolate what your earning potential could be and how many Medical Marijuana Institute Educational Centers will open in cities All Across America in 2010.

Medical Products Division

Medical Marijuana Inc is developing and acquiring proprietary products for the pharmacological marketplace. The company is instituting medically based research to eventually formulate medical products that can clear the FDA approval process. Though this is a futuristic goal and the medical approval process is a lengthy one, various stages of progress on medicinal properties will be made public over time.

Other Cannabis and Hemp related products that do not require FDA approval are being considered by this new Division of MJNA for public marketing. Progress reports will also be regularly made on the development of these products that may foster health and wellness benefits. All products require certain studies be formally conducted in order to make claims of any benefit so derived and the Company's Medical Products Division will be so charged with evaluation and study.

Solutions

Medical Marijuana has developed a suite of solutions to deliver an efficient and secure infrastructure for the Medical Marijuana Industry that provides the tools to industry operators to effectively manage their businesses with the confidence that they are in full compliance.

Tax Collection

The Stored Value Platform System provides verifiable solutions to manage the difficult task of revenue and taxation collection. The provisional patent pending Stored Value Platform System is further described at: http://www.MedicalMarijuanaInc.com/index/html

Scientific Research and Development

MJNA acquired 20 acres of land in the mountains of Southern California in order to develop a research facility targeting medical cannabis strains specific to a wide range of medical conditions. By diligently developing the most efficacious strains and matching those strains to ailments, such as glaucoma, MJNA is poised as the industry leader in medical cannabis genetic research.

About Medical Marijuana Inc

Medical Marijuana Inc (PINKSHEETS: MJNA), the first US public company in the cannabis industry to have its shares traded in the US stock market, recognizes the vast and unequaled opportunities that exist in the rapidly expanding medical marijuana industry. The scientific recognition of marijuana as a powerful medicine, and as an effective, non-narcotic pain reliever, has brought Medical Marijuana use to the forefront of mainstream discussion thus opening the door for safe and lucrative investment opportunities while engaging in compassionate socio-economic models.

Forward-Looking Disclaimer

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties.